Filing Analysis
Spectral AI, Inc. filed an 8-K to announce its quarterly financial results for the period ended June 30, 2026. The company also held a conference call with analysts to discuss these results and other business matters.
📋 Key Facts
- Reported financial results for the quarter ended June 30, 2026 on August 11, 2026.
- Held a conference call with financial analysts on August 11, 2026, at 5:00 pm ET.
- The company is classified as an 'Emerging Growth Company'.
- Common stock trades under ticker MDAI; Redeemable Warrants trade under MDAIW.
Spectral AI, Inc. announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Mrs. Bajko brings significant commercialization experience from MediView XR and Smith+Nephew.
📋 Key Facts
- Darcy Bajko appointed as Chief Commercial Officer (CCO), effective July 31, 2026.
- Annual base compensation set at $315,000 with a target annual bonus of up to 30%.
- Grant of 150,000 stock options under the 2023 Long Term Incentive Plan, vesting over three years.
- Options include accelerated vesting upon a change of control.
- Bajko previously served as VP of Commercialization and Customer Success at MediView XR.
Spectral AI held its 2026 Annual Meeting on May 29, 2026, where stockholders elected the Board of Directors and ratified the appointment of Forvis Mazars LLP as auditors. Most significantly, stockholders approved the issuance of common stock to Hudson Bay Master Fund Ltd. pursuant to a Securities Purchase Agreement dated October 24, 2025.
🚩 Red Flags
- The approval of shares for Hudson Bay Master Fund Ltd. suggests potential dilution of existing shareholders, a common risk for micro-cap companies relying on institutional funding.
📋 Key Facts
- Annual Meeting held May 29, 2026, with 54.30% of eligible shares represented (17,267,570 of 31,823,985 shares).
- Re-elected Board members: J. Michael DiMaio, Richard Cotton, Martin Mellish, Deepak Sadagopan, and Marion Snyder.
- Ratified Forvis Mazars LLP as the independent registered public accounting firm for fiscal year 2026.
- Approved the 'Hudson Bay Proposal' to reserve and issue shares to Hudson Bay Master Fund Ltd. per a Securities Purchase Agreement dated October 24, 2025, in compliance with Nasdaq Rule 5635(d).
Spectral AI, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted De Novo Classification for its DeepView® System. This authorization allows the company to immediately commence commercial distribution activities for the system in the United States.
📋 Key Facts
- On May 26, 2026, Spectral AI received FDA De Novo Classification for its DeepView® System.
- The classification authorizes the company to begin commercial distribution of the system in the U.S.
- The announcement was disclosed under Item 7.01 (Regulation FD Disclosure) with an accompanying press release as Exhibit 99.1.
Spectral AI, Inc. formalized an employment agreement with CEO Vincent S. Capone, establishing a $500,000 base salary and a significant equity grant. The agreement includes a guaranteed minimum bonus and retroactive vesting for a portion of the equity.
🚩 Red Flags
- Guaranteed minimum bonus of $250,000 regardless of performance milestones.
- Retroactive vesting of 100,000 RSUs to April 1, 2026, which is prior to the agreement execution date of April 17, 2026.
📋 Key Facts
- Annual base salary set at $500,000 effective April 17, 2026.
- Eligible for an annual target bonus of up to 100% of base salary, with a guaranteed minimum floor of $250,000.
- Granted 200,000 restricted stock units (RSUs) under the 2023 Long Term Incentive Plan.
- 50% of RSUs (100,000 shares) vested retroactively on April 1, 2026.
- Remaining 50% of RSUs will vest on April 1, 2027, with full acceleration upon a change of control.
Spectral AI, Inc. has appointed David McGuire as its new Chief Financial Officer, effective May 4, 2026. Mr. McGuire brings over 20 years of experience from roles at Solo Brands, EZCORP, and Ernst & Young, and will receive a $330,000 base salary plus equity incentives.
📋 Key Facts
- David McGuire appointed as CFO effective May 4, 2026
- Annual base compensation set at $330,000 with a target bonus of up to 30%
- Granted 150,000 stock options under the 2023 Long Term Incentive Plan, vesting over three years
- McGuire previously served as Chief Accounting Officer at Solo Brands, Inc. and Deputy CFO at EZCORP, Inc.
- McGuire's background includes 14 years at Ernst & Young LLP and experience in material weakness remediation
Spectral AI, Inc. reported its financial results for the fourth quarter and fiscal year ended December 31, 2025. The filing includes a press release and details regarding a conference call held on March 24, 2026, to discuss these results.
📋 Key Facts
- Reported financial results for the quarter and year ended December 31, 2025.
- Hosted a conference call on March 24, 2026, at 5:00 pm Eastern Time.
- The company is classified as an emerging growth company.
- Securities are traded on The Nasdaq Stock Market LLC under symbols MDAI and MDAIW.
Spectral AI announced a $31.7 million funding award from the Biomedical Advanced Research and Development Authority (BARDA). The capital is intended to accelerate the development of additional features for the Company's DeepView® System, an AI-driven burn wound technology.
📋 Key Facts
- Awarded $31.7 million in funding from BARDA on March 18, 2026.
- Funding is specifically for the DeepView® System, an AI-driven burn wound assessment tool.
- The award supports the acceleration of additional feature aspects for the technology.
- The announcement was made via a press release furnished as Exhibit 99.1.
Spectral AI, Inc. has appointed Vincent S. Capone as the new Chief Executive Officer, effective February 9, 2026. This transition involves the dissolution of the Office of the Chairman and a leadership shift from the CFO/General Counsel role to CEO.
🚩 Red Flags
- Dissolution of the Office of the Chairman often indicates significant corporate restructuring or governance changes.
- Internal promotion from CFO to CEO can sometimes signal a period of transition or lack of external candidates, though not always negative.
📋 Key Facts
- Vincent S. Capone appointed as CEO effective February 9, 2026.
- The Board of Directors dissolved the Office of the Chairman on February 9, 2026.
- Mr. Capone previously served as the Company's CFO (since Feb 2024) and General Counsel (since March 2022).
- Capone has a background in private equity and legal practice at firms including Morgan Lewis LLP and Reed Smith LLP.
Spectral AI, Inc. announced the departure of its Chief Commercial Officer, Jeremiah Sparks, effective February 1, 2026. The company stated the departure was not due to any disagreements regarding operations or policies and has entered into a 90-day consulting agreement to ensure a smooth transition.
🚩 Red Flags
- Departure of a key C-suite officer (Chief Commercial Officer) during the company's growth phase.
📋 Key Facts
- Jeremiah Sparks stepped down as Chief Commercial Officer on February 1, 2026.
- The departure is stated to be for 'other opportunities' and not due to disagreements with the company.
- A Consulting Agreement was entered into for a term of 90 days to facilitate transition services.
- Compensation for consulting services is set at $4,000 per week.
Spectral AI, Inc. announced the resignation of Colin Bristow from its Board of Directors, effective January 5, 2026.
📋 Key Facts
- Colin Bristow resigned as a director on January 5, 2026.
- The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Resignation became effective immediately upon tendering.
Spectral AI, Inc. entered into a securities purchase agreement for the issuance of 3,065,000 shares at $1.90 per share and a private placement of warrants totaling approximately 4.9 million potential common stock shares. The transaction is intended to raise roughly $7.6 million in gross proceeds for working capital.
🚩 Red Flags
- Significant potential dilution: The issuance of warrants and pre-funded warrants represents a massive increase in the total share count (approx. 4.9M additional shares).
- Pre-funded warrants with $0.0001 exercise price act as immediate equity, bypassing traditional capital raising mechanics.
- Warrant exercise price ($2.51) is higher than current offering price ($1.90), indicating potential dilution at a premium to the current floor but still significant.
- Registration rights agreement requires the company to file an S-3 within 10 days, likely leading to further immediate market supply.
📋 Key Facts
- Offered 3,065,000 common shares at $1.90 per share.
- Private placement of warrants to purchase up to 4,000,000 shares at an exercise price of $2.51.
- Private placement of pre-funded warrants to purchase up to 935,000 shares at a purchase price of $1.8999 and an exercise price of $0.0001.
- Total aggregate gross proceeds: approximately $7,600,000 (before fees).
- Northland Securities, Inc. acting as placement agent with a 6.00% cash fee on gross proceeds.
- The company must seek stockholder approval for the issuance of shares underlying the warrants.
Spectral AI, Inc. filed an 8-K to announce its quarterly financial results for the period ended June 30, 2025. The company also held a conference call with analysts to discuss these results and other business matters.
📋 Key Facts
- Reported financial results for the quarter ended June 30, 2025.
- Held a conference call on August 12, 2025, at 5:00 pm ET to discuss financial performance and business matters.
- The company is classified as an 'emerging growth company' under SEC rules.
Spectral AI, Inc. announced the submission of a De Novo request to the U.S. FDA for its DeepView System, designed for use in burn care settings and emergency departments.
📋 Key Facts
- Company submitted a De Novo request to the FDA on June 30, 2025.
- The product involved is the 'DeepView System'.
- Target application: Burn care settings (burn centers and emergency departments).
- Filing includes a press release as Exhibit 99.1.
Spectral AI, Inc. has dismissed KPMG LLP as its independent auditor and appointed Forvis Mazars Group (Forvis) as its successor for the fiscal year ending December 31, 2025. The dismissal follows previously reported material weaknesses in internal controls over financial reporting.
🚩 Red Flags
- Auditor change combined with previously reported material weaknesses in internal control over financial reporting.
- Material weaknesses identified in FY2023 and FY2024 regarding financial close processes, operating expenses, accruals, and unbilled revenue.
- Successor auditor (Forvis) has been authorized to respond to inquiries from the predecessor (KPMG) regarding reportable events.
📋 Key Facts
- KPMG LLP dismissed effective May 29, 2025.
- Forvis Mazars Group (Forvis) appointed as the successor independent auditor for FY2025.
- The dismissal was unanimously recommended by the Audit Committee and ratified by the Board of Directors.
- No disagreements regarding accounting principles or auditing scope were reported between the company and KPMG.
- KPMG communicated material weaknesses in internal controls over financial reporting (ICFR) related to financial close processes in 2023 and 2024.
Spectral AI, Inc. announced the appointment of Stanley Micek as Chief Operating Officer (COO) on May 30, 2025. Mr. Micek has been serving in an interim capacity since May 2024.
📋 Key Facts
- Stanley Micek appointed as COO effective May 30, 2025.
- Mr. Micek served as Interim COO starting in May 2024.
- Annual base compensation for the new COO is $360,000 plus a discretionary bonus.
- Previous experience includes Senior VP at MiMedx Group and Chief Commercial Officer at M2Gen Corp.
Spectral AI, Inc. reported the results of its 2025 Annual Meeting of Stockholders held on May 28, 2025. The meeting included the election of six directors and the ratification of KPMG LLP as the company's independent auditor.
📋 Key Facts
- Annual Meeting held on May 28, 2025.
- Quorum reached with 15,551,068 shares represented (60.77% of 25,588,121 eligible shares).
- Six directors elected: J. Michael DiMaio, Colin Bristow, Richard Cotton, Martin Mellish, Deepak Sadagopan, and Marion Snyder.
- KPMG LLP ratified as independent registered public accounting firm for fiscal year 2025.
- Colin Bristow was newly nominated by the Board.
Spectral AI, Inc. filed an 8-K to announce its quarterly financial results for the period ended March 31, 2025. The company also hosted a conference call with analysts to discuss these results and other business matters.
📋 Key Facts
- Reported financial results for the quarter ended March 31, 2025.
- Held a conference call on May 13, 2025, at 5:00 pm ET to discuss financial performance and business updates.
- The filing includes an exhibit (99.1) containing the official press release regarding the results.
Spectral AI, Inc. reported its financial results for the fiscal year ended December 31, 2024, and announced an amendment to the employment agreement of CFO Vincent Capone.
🚩 Red Flags
- None identified in this specific filing text.
📋 Key Facts
- Financial results for the quarter and year ended Dec 31, 2024 were released on March 27, 2025.
- CFO Vincent Capone's employment agreement was amended effective March 26, 2025.
- Amended compensation includes $440,000 annual base salary and a potential annual bonus up to the amount of his base salary (min. $250,000).
- 100,000 RSUs vested as of March 26, 2025; remaining 50,000 RSUs vest on Dec 31, 2025.
- Grant of 75,000 non-qualified stock options to the CFO with staggered vesting starting April 1, 2025.
Spectral AI, Inc. announced a dual-track financing event involving a $2.7 million equity/warrant offering and a significant $15.0 million debt facility from Avenue Capital Group. The company is securing immediate working capital through high-interest variable rate debt secured by substantially all corporate assets.
🚩 Red Flags
- High-interest variable rate debt (floor of 12.75%) increases financial risk during volatility.
- Debt is secured by 'substantially all of the assets of the Company', increasing bankruptcy risk for common shareholders.
- Significant dilution potential from the issuance of over 2 million warrants and shares.
- Contingent debt tranches tied to regulatory (FDA) milestones create high execution risk.
📋 Key Facts
- Equity Offering: Sold 2,076,923 shares of common stock at $1.30 per share.
- Warrant Issuance: Issued 2,076,923 warrants with an exercise price of $1.80 per share.
- Debt Financing: Entered into a Loan and Security Agreement (LSA) for up to $15.0 million in funding from Avenue Capital Group.
- Initial Debt Drawdown: An initial $8.5 million has been drawn down.
- Interest Rate: Variable rate equal to the greater of Prime + 5.25% or 12.75%.
- Tranche 2 Contingency: An additional $6.5 million in debt is contingent upon FDA clearance of the DeepView System and a further $7.0 million equity raise.
- Security Interest: The debt is secured by a security interest in substantially all of the Company's assets.
Spectral AI, Inc. issued an 8-K to announce the results of its DeepView System performance following the completion of a Burn Validation Study. The filing primarily serves as a vehicle to furnish a press release containing clinical/performance data.
📋 Key Facts
- The company completed a 'Burn Validation Study' for its DeepView System.
- Results of the study were announced via a press release dated March 17, 2025.
- The filing is made under Item 7.01 (Regulation FD Disclosure) and does not constitute 'filed' information subject to Section 18 liabilities.
Spectral AI, Inc. completed a registered direct offering of 270,900 shares at $1.66 per share to UK-based investors on December 11, 2024. The company also secured an option for investors to purchase up to $5 million in additional shares.
🚩 Red Flags
- Dilutive offering: The issuance of new shares at $1.66 per share may dilute existing shareholders.
- Potential for significant future dilution via the $5 million investor option.
📋 Key Facts
- Offered 270,900 shares of common stock at a price of $1.66 per share.
- Gross proceeds from the initial offering totaled $449,694.
- Investors hold an option to purchase additional shares up to $5,000,000 or one-third of public float.
- Additional shares under the option are priced at the lesser of the previous day's closing price or the 5-day VWAP.
- SP Angel Corporate Finance LLP acted as the exclusive placement agent with a 7.00% cash fee.
Spectral AI, Inc. entered into a securities purchase agreement on November 18, 2024, to sell common stock and pre-funded warrants to an investor at $1.38 per share/warrant. The deal includes an option for the investor to purchase up to $5 million in additional shares.
🚩 Red Flags
- Significant dilution potential due to pre-funded warrants and additional share options.
- Right of first refusal granted to investor limits company's future fundraising flexibility.
- Price protection/adjustment clause for the investor in the event of a 20% price drop.
📋 Key Facts
- Offering of 920,000 shares of common stock at $1.38 per share.
- Issuance of pre-funded warrants to purchase up to 725,000 shares at $1.38 per warrant (exercise price of $0.001).
- Investor has an option to purchase additional shares up to a 'Commitment Amount' of the lesser of $5,000,000 or one-third of public float.
- The investor was granted a right of first refusal for any future equity offerings until the commitment amount is met.
- Price adjustment clause: if stock price drops by 20% on the closing day, the offering price may be amended.
Spectral AI, Inc. announced a registered direct offering of 500,000 shares at $1.80 per share to an investor, following a previously entered securities purchase agreement for up to $5,000,000 in total capacity.
🚩 Red Flags
- Potential dilution: The issuance of 500,000 shares at $1.80 per share represents significant new supply.
- Right of First Refusal (ROFR): Granting an investor ROFR on future equity offerings can be a restrictive term that may deter other potential investors.
📋 Key Facts
- Investor exercised notice on December 12, 2024, to purchase 500,000 shares of Common Stock.
- Offering price is set at $1.80 per share.
- The transaction is part of a larger securities purchase agreement dated November 18, 2024, for up to $5,000,000 in aggregate proceeds.
- Investor holds an option to purchase additional shares up to the lesser of $5,000,000 or one-third of public float.
- The Investor has been granted a right of first refusal (ROFR) for any equity offering during the term of the agreement.
Spectral AI, Inc. announced that it has regained compliance with all applicable Nasdaq listing requirements. The company received a 'moot' letter from Nasdaq on December 20, 2024, confirming that further hearings regarding its continued listing are no longer necessary.
🚩 Red Flags
- Previous non-compliance with Nasdaq listing requirements (implied by the need for a 'moot' letter and hearing).
📋 Key Facts
- On December 20, 2024, the Company received a 'moot' letter from Nasdaq.
- The company has regained compliance with all applicable Nasdaq Listing Requirements for the Nasdaq Capital Market.
- A further hearing regarding compliance is no longer necessary.
- The announcement was made via press release on December 23, 2024.
Spectral AI, Inc. has received a delisting notice from Nasdaq after failing to regain compliance with the Market Value Rule by the December 2, 2024 deadline. The company has requested a hearing before the Nasdaq Listing Qualifications Panel to seek an extension of up to 180 days to meet the $35 million market capitalization requirement.
🚩 Red Flags
- Delisting notice received due to failure to meet Nasdaq's Market Value Rule (Rule 5550(b)(2)).
- History of non-compliance dating back to a June 3, 2024 notification.
- Uncertainty regarding the Panel's decision to grant an extension.
📋 Key Facts
- The Company failed to maintain a minimum market value of listed securities of $35,000,000 for the required period ending December 2, 2024.
- Nasdaq issued a delisting notice on December 5, 2024.
- The Company has requested a hearing before the Nasdaq Listing Qualifications Panel to present a compliance plan.
- A successful panel request could grant an extension of up to 180 days from December 2, 2024.
- The company claims its current market capitalization is above $35,000,000.
Spectral AI, Inc. announced the resignation of CEO Peter M. Carlson effective October 14, 2024. To manage the transition and support clinical/commercial operations, the Board has created an 'Office of the Chairman' consisting of several key executives.
🚩 Red Flags
- Sudden departure of the Chief Executive Officer (CEO).
- Creation of an 'Office of the Chairman' suggests a period of leadership instability or lack of a clear successor.
- Transition to interim/distributed management structure can lead to operational friction.
📋 Key Facts
- CEO Peter M. Carlson resigned as CEO and Director on October 14, 2024.
- Mr. Carlson will serve as a consultant for an initial term of 15 months to assist in management transition.
- Consulting compensation is set at $27,500 per month plus accrued benefits.
- The Board created the 'Office of the Chairman' to handle day-to-day operations.
- The Office of the Chairman includes CFO/General Counsel Vincent Capone, CCO Jeremiah Sparks, Interim COO Stan Micek, and GM Louis Percoco.
Spectral AI, Inc. filed an 8-K to furnish an investor presentation dated August 13, 2024. This is a routine disclosure under Regulation FD to provide updated information to the public.
📋 Key Facts
- The company posted an Investor Presentation to its website (www.spectral-ai.com) on August 13, 2024.
- The presentation is furnished as Exhibit 99.1 and is not considered 'filed' for purposes of Section 18 liability.
- The filing includes common stock (MDAI) and redeemable warrants (MDAIW) information.
Spectral AI, Inc. issued a report regarding its ongoing efforts to prompt Nasdaq into investigating potential market manipulation, specifically naked short-selling of its common stock.
🚩 Red Flags
- Allegations of market manipulation (naked short-selling) can lead to extreme volatility and liquidity issues.
- The inquiry is being driven by a Board member who is also the largest shareholder, which may present potential conflicts of interest or signaling concerns regarding stock price stability.
📋 Key Facts
- The company is seeking a Nasdaq review of potential market manipulation.
- The inquiry is being led by Erich Spangenberg, a member of the Board of Directors and the Company's largest shareholder.
- The alleged manipulation primarily involves naked short-selling of the Company's common stock.
- A letter was sent to Nasdaq Stock Market LLC on July 15, 2024, regarding this matter.
Spectral AI, Inc. has formally requested inquiries from Nasdaq and state regulators in Texas, Florida, and Louisiana regarding alleged market manipulation of its common stock, specifically citing potential naked short selling.
🚩 Red Flags
- Allegations of naked short selling often precede significant volatility or legal disputes.
- Discrepancy between OBO/NOBO lists and total float suggests potential liquidity or settlement issues in the underlying stock.
- The inquiry is led by a Board member who is also the largest shareholder, which can introduce conflicts of interest or be perceived as an attempt to influence market sentiment.
📋 Key Facts
- The company sent letters to the Nasdaq Stock Market LLC and state securities regulatory organizations in Texas, Florida, and Louisiana on June 24, 2024.
- Management alleges that the combined number of shares on the Non-Objective Beneficial Owners (NOBO) List and Objecting Beneficial Owners (OBO) List exceeds the total float by a significant percentage.
- The company claims this discrepancy is an indicator of illegal 'naked' short selling by institutional investors.
- The inquiry into market manipulation is being led by Erich Spangenberg, a member of the Board of Directors and the Company’s largest shareholder.
Spectral AI, Inc. received a notice from Nasdaq stating it is not in compliance with the minimum market value of listed securities requirement ($35 million). The company has a 180-day period to regain compliance.
🚩 Red Flags
- Delisting notice regarding minimum market value requirement.
- Failure to maintain a $35M market capitalization indicates significant loss in shareholder value or low stock price.
- Risk of delisting if compliance is not met by December 2, 2024.
📋 Key Facts
- Received notice on June 3, 2024, regarding non-compliance with Nasdaq Listing Rule 5550(b)(2).
- The deficiency is based on the closing bid price failing to maintain a minimum market value of $35,000,000 for the last 31 consecutive business days.
- The company has a compliance period until December 2, 2024, to regain compliance.
- Compliance can be achieved if the closing market capitalization is at or above $35,000,000 for 10 (or potentially 20) consecutive business days.
Spectral AI, Inc. reported the results of its 2024 Annual Meeting of Shareholders held on May 14, 2024. The meeting included the election of directors, ratification of a new long-term incentive plan, re-appointment of KPMG LLP as auditor, and authorization for share issuance under a standby equity purchase agreement.
🚩 Red Flags
- Authorization for standby equity issuance (PIPE-style mechanism) can lead to future dilution for existing shareholders.
📋 Key Facts
- Annual Meeting held on May 14, 2024, with 53.14% of eligible shares represented (9,289,312 shares).
- Board expanded from six to seven members; Erich Spangenberg was appointed as a director.
- Shareholders ratified the adoption of the 2023 Long Term Incentive Plan, which will replace the 2018 and 2022 plans.
- KPMG LLP was re-appointed as independent registered public accounting firm for fiscal year 2024.
- Shareholders authorized the reservation and issuance of 6,369,937 shares of Common Stock to YA II PN, Ltd. pursuant to a Standby Equity Purchase Agreement dated March 20, 2024.
Spectral AI, Inc. announced the resignation of its Chief Operating Officer, Dr. Niko Pagoulatos, effective March 29, 2024. The company has appointed Stan Micek as interim COO to fill the vacancy.
🚩 Red Flags
- Departure of a key C-suite officer (COO) can create operational instability or transition friction.
📋 Key Facts
- Dr. Niko Pagoulatos resigned as COO on March 29, 2024; he had served in the role since November 2022.
- The company stated the resignation was not due to any disagreement regarding operations, policies, or practices.
- Stan Micek appointed as interim Chief Operating Officer effective April 8, 2024.
- Interim COO Stan Micek previously served as SVP of Business Development & Strategy at MiMedx Group, Inc.
Spectral AI, Inc. announced the appointment of Jeremiah Sparks as Chief Commercial Officer on April 1, 2024. Mr. Sparks brings significant commercialization experience from Avita Medical, Inc.
📋 Key Facts
- Appointment of Jeremiah Sparks as Chief Commercial Officer effective April 1, 2024.
- Sparks previously served at Avita Medical, Inc. as Senior Director of Commercialization and VP of Global Strategy.
- Compensation includes an annual base salary of $295,000.
- Eligible for a discretionary bonus of up to 30% of base salary.
- Equity incentive: Option grant for 30,000 shares of common stock vesting in three annual installments.
Spectral AI, Inc. filed an 8-K to announce its financial results for the quarter and fiscal year ended December 31, 2023. The filing includes a press release detailing the company's operational and financial performance.
📋 Key Facts
- Reported financial results for the quarter and year ended December 31, 2023.
- Held a conference call with financial analysts on March 27, 2024, to discuss results and business matters.
- The filing is categorized under Item 2.02 (Results of Operations and Financial Condition).
Spectral AI, Inc. entered into a Standby Equity Purchase Agreement (SEPA) with Yorkville, allowing the company to sell up to $30 million in common stock at a discount to market price. The deal includes an immediate $5 million pre-paid advance via convertible promissory notes.
🚩 Red Flags
- Highly dilutive financing structure (SEPA) common in micro-cap distressed/growth companies.
- Significant discount to market price for Yorkville (97% of VWAP).
- Convertible notes with a 18% default interest rate penalty.
- Variable conversion price for debt repayment can be as low as $0.47 (Floor Price), creating massive dilution risk.
📋 Key Facts
- Entered into SEPA with YA II PN, LTD (Yorkville) on March 20, 2024.
- Total equity sale capacity: up to $30.0 million in common stock.
- Immediate Pre-Paid Advance of $5.0 million via convertible promissory notes at a fixed conversion price of $3.16 per share.
- Two subsequent tranches of $5.0 million and $2.5 million available under specific conditions.
- Shares sold under SEPA are priced at 97% of the lowest daily VWAP over three consecutive trading days.
- Convertible notes include a repayment obligation with an interest rate that jumps from 0% to 18% upon default.
Spectral AI, Inc. announced a significant leadership transition effective February 29, 2024, featuring the resignation of CEO Wensheng Fan and the appointment of Peter M. Carlson as the new CEO.
🚩 Red Flags
- Sudden departure of the CEO and transition to a 'Chief Innovation Strategist' role can sometimes indicate friction or a forced exit, though not explicitly stated.
- High executive compensation packages (total target cash $1.1M for CEO) in a micro-cap context.
📋 Key Facts
- CEO Wensheng Fan resigned from his roles as CEO and Director on Feb 29, 2024; he will transition to Chief Innovation Strategist for a 3-year term.
- Peter M. Carlson appointed as CEO, effective Feb 29, 2024 (formerly CFO of the company).
- Vincent S. Capone appointed as CFO and General Counsel, effective Feb 29, 2024.
- New CEO Peter Carlson to receive $550,000 base salary plus a $550,000 target bonus and 150,000 RSUs.
- New CFO Vincent Capone to receive $400,000 base salary plus a $400,000 target bonus and 150,000 RSUs.
- The company entered into a Separation and Release Agreement with Wensheng Fan involving an annual payment of $200,000 for services.
Spectral AI, Inc. announced that its predictive software, DeepView AI®-Burn, has received UKCA authorization for burn wound diagnosis in the United Kingdom. The company also anticipates generating revenue in the second half of 2024.
📋 Key Facts
- DeepView AI®-Burn obtained UK Conformity Assessed (UKCA) authorization for use in the United Kingdom.
- The software is designed to aid in burn wound diagnosis.
- Management anticipates revenue generation in H2 2024.
Spectral AI, Inc. filed an 8-K to furnish an investor presentation dated February 13, 2024. The filing is a routine disclosure under Regulation FD to provide updated information to the public.
📋 Key Facts
- Company posted an investor presentation to its website on February 13, 2024.
- The presentation is furnished as Exhibit 99.1 and is not considered 'filed' for purposes of Section 18 liability.
- The company intends to use the presentation in discussions with investors and analysts.
Spectral AI, Inc. announced the appointment of Dr. J. Michael DiMaio to its Board of Directors, effective February 7, 2024. Dr. DiMaio is a founder and former CEO/Chairman who previously exited the company in 2020 following an amicable dispute.
🚩 Red Flags
- Historical 'amicable dispute' mentioned regarding his previous departure in 2020 (though context suggests resolution).
📋 Key Facts
- Dr. J. Michael DiMaio appointed to the Board of Directors effective February 7, 2024.
- DiMaio is a founder and served as CEO and Chairman from 2011 to 2020.
- He previously exited the company in 2020 after an 'amicably resolved' dispute.
- Dr. DiMaio is currently Chief of Staff at Baylor Scott & White-The Heart Hospitals.
- His professional background includes overseeing 650+ physicians and managing research with over $150 million in funding from NIH, AHA, NSF, DoD, HHS, and BARDA.
Spectral AI, Inc. filed an 8-K to furnish a shareholder letter providing operational updates and expectations for the year 2024. The filing is made under Item 7.01 (Regulation FD Disclosure) and does not contain new material agreements or financial restatements.
📋 Key Facts
- The company issued a shareholder letter dated February 5, 2024.
- The letter provides updates on Company operations and expectations for the fiscal year 2024.
- The disclosure is furnished under Item 7.01 rather than filed, meaning it is not subject to certain liabilities under Section 18 of the Exchange Act.
Spectral AI, Inc. announced the resignation of Michael Murphy from its Board of Directors, effective January 30, 2024.
📋 Key Facts
- Michael Murphy resigned as a director on January 30, 2024.
- The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.